Abstract

In most nations, cerebral palsy, which af fects 1 in 500 newborns and has an estimated incidence of 17 million people globally, is the most frequent cause of childhood-onset, lifelong physical disability. The term «cerebral palsy» refers to a group of children that share characteristics of a non-progressive brain injury or lesion that was sustained during antenatal, perinatal, or early postnatal life rather than a disease entity in the traditional sense. The type of movement abnormality, the degree of functional capacity and limitation, and the body areas affected vary widely among the clinical symptoms of cerebral palsy. Although there is presently no cure for brain injury, efforts to prevent and treat it are progressing. Although cerebral palsy affects people for their whole lives, the majority of research efforts and management techniques for the condition currently concentrate on the needs of children. The treatments discovered included nanomedicine, stem cell therapy, physiotherapy, occupational therapy, and medicinal and surgical techniques. Further research is required to adapt therapies like cord blood therapy, nanomedicine, and stem cell therapy in clinical settings.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call